When was Cradle founded?

Cradle was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Cradle located?

Cradle is headquartered in Delft, Netherlands.

Who is the current CEO of Cradle?

Stef Van Grieken of Cradle. They have also founded 1 company and are angel investors in 2 startups.

How many employees does Cradle have?

As of Apr 30, 2026, the latest employee count at Cradle is 119.

Is Cradle a funded company?

Cradle is a funded company, having raised a total of $103M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 17, 2022.

When was the latest funding round of Cradle?

Cradle's latest funding was a $***** Series B round on Nov 26, 2024, with participation from 3 investors.

Where does Cradle rank among its competitors?

Cradle ranks 12th amongst 67 active competitors, of which 36 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Converge, which secured $25M in Jan, 2026.

Who are the top competitors of Cradle?

Cradle's top competitors include Nimbus Therapeutics, Generate Biomedicines and Profluent Bio. Among them, Converge secured the most recent funding round in January, 2026.

Cradle - 2026 Company Profile, Team, Funding & Competitors

Cradle is a series B company based in Delft (Netherlands), founded in 2021 by Jelle Prins and Stef Van Grieken. It operates as a Provider of chemoproteomics solutions for protein design and development. Cradle has raised $103M in funding from investors like Index Ventures, IVP and Kindred Capital. The company has 67 active competitors, including 36 funded and 5 that have exited. Its top competitors include companies like Nimbus Therapeutics, Generate Biomedicines and Profluent Bio.

Company Details

Provider of chemoproteomics solutions for protein design and development. The platform enables researchers to design proteins using predictive algorithms and AI design suggestions. It also offers 3D structure prediction, optimizing thermostability and codon expression.

Website: www.cradle.bio/
Email ID: *****@cradle.bio

Key Metrics

Founded Year

2021

Location

Delft, Netherlands

Stage

Series B

Total Funding

$103M in 3 rounds

Latest Funding Round

Series B, Nov 26, 2024, $*****

Investors

Index Ventures & 8 more

Ranked

12^th among 67 active competitors

Employee Count

119 as on Apr 30, 2026

Investment & Acquisitions

BIOGENES TECHNOLOGIES

Similar Companies

Innovaccer & 2370 more

View Cradle's full profile

Cradle has raised a total funding of $103M over 3 rounds. Its first funding round was on Nov 17, 2022. Its latest funding round was a Series B round on Nov 26, 2024 for $*****. 3 investors participated in its latest round. Cradle has 5 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Cradle:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 26, 2024	5189276	Series B	3145241	5392118	2903590	6720188
Nov 27, 2023	8070846	Series A	8042166	5358979	9030872	Kindred Capital & 2 more
Nov 17, 2022	3188728	Seed	5190603	6766965	Index Ventures & 1 more	Feike Sijbesma & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Cradle's funding rounds and investors

The founders of Cradle are Jelle Prins and Stef Van Grieken. Stef Van Grieken is the CEO of Cradle.

Here are the details of Cradle's key team members:

Jelle Prins: Co-Founder of Cradle and founder of 1 other company. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Stef Van Grieken: Co-Founder & CEO of Cradle. They are also an angel investor in 2 startups.
Contact Info: 1 email address

View details of Cradle's Founder profiles and Board Members

Cradle's employee count trend

Cradle has 119 employees as of Apr 26. Here is Cradle's employee count trend over the years:

Uncover Cradle's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cradle include Nimbus Therapeutics, Generate Biomedicines and Profluent Bio. Here is the list of Top 10 competitors of Cradle, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nimbus Therapeutics 2009, Cambridge (United States), Series F	Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases	$637M	BVF Partners, Atlas Venture & 20 others	68/100
2nd	Generate Biomedicines 2018, Somerville (United States), Public	Developer of a platform for generating novel protein-based therapeutic modalities	$693M	March Capital, Amgen & 14 others	66/100
3rd	Profluent Bio 2022, Berkeley (United States), Series B	Provider of an artificial intelligence-based protein design platform	$150M	Bezos Expeditions, Altimeter Capital & 6 others	64/100
4th	Seismic 2019, Watertown (United States), Series B	AI-assisted platform for drug discovery and development	$247M	Bessemer Venture Partners, Lightspeed Venture Partners ... & 12 others	63/100
5th	Eikon 2019, Hayward (United States), Public	Protein tracking and measuring tool for drug discovery	$1.16B	The Column Group, ADIA & 22 others	62/100
6th	Vividion Therapeutics 2016, Oceanside (United States), Acquired	Pioneering chemoproteomics and covalent chemistry for precision therapeutics targeting undruggable disease drivers	$271M	Boxer Capital, Logos & 20 others	61/100
7th	Nomic 2017, Montreal (Canada), Series B	Provider of next-generation proteomics platform for drug discovery and protein analysis	$63M	Lux Capital, Amplitude & 13 others	56/100
8th	Orbit Discovery 2015, Oxford (United Kingdom), Series A	Developer of a drug discovery platforms by peptide display engine	$15.7M	Oxford Science Enterprises, Oxford University Innovation ... & 11 others	54/100
9th	AI Proteins 2021, Boston (United States), Series A	Developer of de novo designed miniproteins for therapeutic applications	$59.7M	Mission BioCapital, Sante & 3 others	53/100
10th	Converge 2024, Wilmington (United States), Series A	Developer of GenAI computational tools for drug discovery and manufacturing	$30.5M	Bessemer Venture Partners, TLV Partners & 2 others	53/100
12th	Cradle 2021, Delft (Netherlands), Series B	Provider of chemoproteomics solutions for protein design and development	$103M	IVP, Kindred Capital & 7 others	64/100